What is Center for Allergy?
The Center for Allergy and Asthma Care operates as a premier provider of comprehensive medical services, focusing on the diagnosis and management of allergic conditions and asthma for pediatric and adult populations. The organization distinguishes itself through a clinical model anchored by board-certified physicians who utilize advanced immunotherapy and diagnostic testing to deliver personalized patient outcomes. By maintaining a high standard of care for conditions ranging from allergic rhinitis to complex food allergies, the center has established itself as a vital community leader. Its market position is defined by a commitment to evidence-based medicine and a scalable service delivery framework that addresses the increasing prevalence of respiratory and immune-related health challenges.
How much funding has Center for Allergy raised?
Center for Allergy has raised a total of $341K across 2 funding rounds:
Debt
$150K
Debt
$191K
Debt (2020): $150K with participation from PPP
Debt (2021): $191K led by PPP
Key Investors in Center for Allergy
PPP
Public-Private Partnership
What's next for Center for Allergy?
With the successful completion of this late-stage financing round, the Center for Allergy is well-positioned to accelerate its strategic initiatives. The capital will likely be deployed to enhance clinical infrastructure, expand the reach of its specialized treatment programs, and potentially integrate digital health solutions to improve patient engagement and long-term care management. As the organization transitions into this next phase of development, the focus will remain on scaling its high-quality care model while maintaining the rigorous clinical standards that have defined its reputation. Investors and stakeholders will be monitoring the center's ability to leverage this liquidity to capture a larger share of the allergy and asthma treatment market, ensuring sustained operational excellence and long-term value creation.
See full Center for Allergy company page
